Media & Press2019-09-17T16:08:49-04:00

    Bexion Pharmaceuticals, Inc. to Present at the 2021 Association for Cancer Immunotherapy (CIMT) Annual Meeting

    April 20, 2021|

    FOR IMMEDIATE RELEASE [Covington, KY---April 20, 2021] Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced today that an abstract submitted for an eTalk Session at the CIMT annual meeting to be held virtually May 10-12, 2021 has been chosen for presentation. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the ... Read More

      New Segment of Advancements to Focus on Breakthroughs in Targeted Cancer Cell Treatment

      April 12, 2021|

      Jupiter, FL— The award-winning series, Advancements with Ted Danson, will focus on an innovative, targeted approach to treating a range of diseases during 3Q/2021. Check local listings for more information. The diseases for which medicine offers few effective options – advanced cancer (or even early-stage cancer for certain types), neurodegenerative diseases and autoimmune diseases – persist because ... Read More

        Bexion Pharmaceuticals Announces the Addition of Olivia F. Kirtley to Board of Directors

        February 22, 2021|

        FOR IMMEDIATE RELEASE Covington, KY February 22, 2021 Bexion Pharmaceuticals, Inc. announced today that it has added Olivia F. Kirtley to its Board of Directors. Ms. Kirtley, a Certified Public Accountant and Chartered Global Management Accountant, is a business consultant on strategic, risk and corporate governance issues. She brings to Bexion extensive experience as ... Read More

        All Press